89 results
management pharmacology treatment infections hivaids opportunistic prevention antibiotics medications algorithm diagnosis comparison indications infectiousdiseases meningitis cardiology dosing bacterial cryptococcus empiric
IDSA Recommendations for empirical antimicrobial therapy for purulent meningitis based on patient age and specific predisposing
IDSA Recommendations ... antimicrobial therapy ... condition #IDSA
►
 IDSA - Antimicrobial Therapy for Staphylococcal and Streptococcal Skin and Soft Tissue Infections • Impetigo (Staphylococcus
IDSA - Antimicrobial ... Therapy for Staphylococcal ... management #treatment #idsa
Recommendations for specific antimicrobial therapy in bacterial meningitis based on isolated pathogen and susceptibility testing. #IDSA #Meningitis
antimicrobial therapy ... #IDSA #Meningitis
►
 IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days) Preferred
IDSA Recommendations ... days) Preferred Therapy ... mucoadhesive buccal tablet ... chew, or crush tablet ... candida #mucosal #IDSA
Perianal Crohn's Disease - IBD Algorithm • 5-40% w perianal fistula • ↑ risk if colonic
refractory to medical therapy ... Crohns #Disease #IBDAlgorithm
FDA-Approved 1st line Medications for Tobacco Cessation Treatment Nicotine patch, Nicotine lozenge, Nicotine gum, Nicotine inhaler, Nicotine
, Varenicline (tablet ... release (SR) (tablet ... Tobacco #Cessation #Therapy ... #Comparison #Table
IDSA Algorithm for the Initial Management of Fever and Neutropenia LOW RISK • Antidpated neutropenia < 7
IDSA Algorithm for ... and clinically stable ... neutropenic #fever #IDSA
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals Induction therapy: • AmBd (0.7–1.0
IDSA Treatment Recommendations ... Individuals Induction therapy ... for induction therapy ... for maintenance therapy ... Meningoencephalitis #IDSA
Outpatient Treatment of with Community-Acquired Pneumonia (CAP) No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
• Combination therapy ... fluoroquinolone #IDSA
Summary of characteristics of Antianginal Drugs DRUG CLASS, ADVERSE EFFECTS AND DRUG INTERACTIONS #Antianginal #Medications #Cardiology
Pharmacology #Management #Therapy ... #Table #Overview
No results found for "IBDAlgorithm therapy idsa table"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #IBDAlgorithm #therapy #idsa #table